Development of a method for cancer risk assessment by genomic mutation analysis
Not Applicable
- Conditions
- Healthy adults, Cancer patients
- Registration Number
- JPRN-UMIN000039526
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 171
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects deemed inappropriate to participate in this study by the principle investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the patterns, frequencies, positions and distributions of somatic mutations
- Secondary Outcome Measures
Name Time Method 1. Estimation of relevant environmental mutagens by the evaluation of the patterns and frequencies, or sequence context of somatic mutations 2. Estimation of mutation acquiring processes by the evaluation of positions of mutations and correlations to known epigenetic markers